Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jennifer Tappenden"'
Autor:
Graham A. Colditz, Debbie L. Bennett, Jennifer Tappenden, Courtney Beers, Nicole Ackermann, Ningying Wu, Jingqin Luo, Sarah Humble, Erin Linnenbringer, Kia Davis, Shu Jiang, Adetunji T. Toriola
Publikováno v:
Cancer Causes & Control. 33:623-629
PurposeThe Joanne Knight Breast Health Cohort was established to link breast cancer risk factors, mammographic breast density, benign breast biopsies and associated tissue markers, and blood markers in a diverse population of women undergoing routine
Autor:
Ai Zhang, Deyali Chatterjee, Jie Liu, Jennifer Tappenden, Graham A. Colditz, Yin Cao, Thomas J. Walsh, Hanyu Chen, Xiaoyu Zong, Ryan C. Fields
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:YIA20-002
Autor:
Bradley A, Fritz, Christopher R, King, Divya, Mehta, Emily, Somerville, Alex, Kronzer, Arbi, Ben Abdallah, Troy, Wildes, Michael S, Avidan, Eric J, Lenze, Susan, Stark, Jennifer, Tappenden
Publikováno v:
JAMA Network Open. 5:e221938
Falls after elective inpatient surgical procedures are common and have physical, emotional, and financial consequences. Close interactions between patients and health care teams before and after surgical procedures may offer opportunities to address
Autor:
Shivon Tannan, Graham A. Colditz, Bettina F. Drake, Jennifer Tappenden, Melody S. Goodman, Victoria V. Anwuri, Mark Sanford, Sherrill Jackson
Publikováno v:
Journal of Community Health
Breast cancer screening combined with follow-up and treatment reduces breast cancer mortality. However, in the study clinic, only 12 % of eligible women ≥40 years received a mammogram in the previous year. The objective of this project was to imple
Autor:
Dione M. Farria, Sherrill Jackson, Timothy J. Eberlein, Katherine Mathews, Victoria V. Anwuri, Jennifer Tappenden, Brian C. Springer, Lannis E. Hall, Graham A. Colditz, Melody S. Goodman
Publikováno v:
Cancer Causes & Control. 24:1797-1809
Participation in therapeutic clinical trials rarely reflects the race and ethnic composition of the patient population. To meet National Institutes of Health-mandated goals, strategies to increase participation are required. We present a framework fo
Autor:
Dione M. Farria, Katherine Mathews, Jennifer Tappenden, Graham A. Coldtiz, Victoria V. Anwuri, Lannis Hall, Brian C. Springer, Sherrill Jackson, Timothy J. Eberlein
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 19:A40-A40
Purpose: Participation in therapeutic clinical trials rarely reflects the race and ethnic composition of the patient population. To meet NIH-mandated goals, strategies to increase participation are required. Here, we present a framework for instituti